Wall Street Wizardry
  • Business
  • World News
  • Politics
  • Investing
  • Business
  • World News
  • Politics
  • Investing

Wall Street Wizardry

Investing

Critical Metals Secures US$120 Million Loan LOI for Tanbreez Rare Earths Project

by admin June 20, 2025
June 20, 2025
Critical Metals Secures US$120 Million Loan LOI for Tanbreez Rare Earths Project

Critical Metals (NASDAQ:CRML) got a boost on Monday (June 16), landing a letter of interest (LOI) for a non-dilutive US$120 million funding package from the Export-Import Bank of the US (EXIM).

The funds would be used to advance its Tanbreez rare earths project in Southern Greenland.

Touted as one of the world’s largest rare earths deposits, Tanbreez is expected to produce up to 85,000 metric tons of rare earth material annually, with more than 27 percent classified as heavy rare earth elements.

“This is a tremendous milestone for Critical Metals Corp which highlights to the rare earths supply chain, Western Governments and investors that Tanbreez is a world-class asset that will provide mission-critical rare earth metals to counter China’s continued dominance,” said Critical Metals CEO and Chairman Tony Sage.

The funding would support pre-production, technical studies and early mining activities. EXIM’s financing falls under its new Supply Chain Resiliency Initiative and comes with a 15 year repayment term.

Critical Metals acquired a controlling stake in Tanbreez in June 2024 in a transaction valued at up to US$211 million. It expects the asset to require US$290 million in capital expenditure to advance to initial commercial production.

The US$120 million from EXIM would support key early stage work at Tanbreez, including technical and economic studies, pre-production activities and the start of mining operations.

The company is aiming to complete a definitive feasibility study by late 2025.

Critical Metals also plans to invest an additional US$10 million in exploration this year, giving it the option to increase its ownership in the project to 92.5 percent through the acquisition of a further 50.5 percent stake.

“We are now razor focused to put Tanbreez into production as soon as possible,’ said Sage.

Securities Disclosure: I, Gabrielle de la Cruz, hold no direct investment interest in any company mentioned in this article.

This post appeared first on investingnews.com

previous post
Mali Court Seizes Control of Barrick Gold Mine Amid Escalating Dispute
next post
Prospectus

Related Posts

Rare Earths Stocks: 9 Biggest Companies in 2025

September 4, 2025

Gary Wagner: Gold Thriving Amid Uncertainty, Price Uptrend...

April 12, 2025

6 Biggest Crypto Mining Stocks

February 7, 2025

Target’s Statement

March 11, 2025

Psychedelics Market Update: H1 2025 in Review

July 31, 2025

Kaiser’s Record-Breaking First Weekly Gold Pour

May 26, 2025

Operational Update

September 8, 2025

Top 10 Cobalt Producers by Country

February 20, 2025

China, US Rare Earths Tensions Ramp Up Ahead...

October 20, 2025

High Grade Gold Intercepts Confirm Kpali Discovery

February 17, 2025

    Join our mailing list to get access to special deals, promotions, and insider information. Your exclusive benefits await! Enjoy personalized recommendations, first dibs on sales, and members-only content that makes you feel like a true VIP. Sign up now and start saving!


    By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.

    Editors’ Picks

    • 1

      Universal’s ‘Wicked: For Good’ creates a unique marketing challenge

      January 26, 2025
    • 2

      Netflix shares soar as company reports surging revenue, tops 300 million subscribers

      January 23, 2025
    • 3

      Financial Agreement signed releasing $2M grant

      January 23, 2025
    • 4

      US security contractor will take charge of key checkpoint in Gaza as Israeli forces withdraw

      January 25, 2025
    • 5

      Trump re-designates Iranian-backed Houthis as terrorists: ‘Threaten[s] security of American civilians’

      January 23, 2025
    • 6

      Cyclopharm Signs US Agreement with HCA Healthcare for Technegas®

      January 23, 2025
    • 7

      FDA officially authorizes Zyn nicotine pouches for sale following health review

      January 23, 2025
    • About us
    • Contacts
    • Privacy Policy
    • Terms and Conditions
    • Email Whitelisting

    Disclaimer: wallstreetwizardry.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.


    Copyright © 2025 wallstreetwizardry.com | All Rights Reserved